These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 11072722
1. [Concentration of alkaline phosphatase (AP) and AP/albumin ratio in bronchoalveolar lavage (BAL) for the diagnosis of interstitial lung diseases]. Schildge J, Klar B, Weinstock N. Pneumologie; 2000 Sep; 54(9):385-91. PubMed ID: 11072722 [Abstract] [Full Text] [Related]
2. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases]. Schildge J, Klar B, Hardung-Backes M. Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558 [Abstract] [Full Text] [Related]
3. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Reichenberger F, Schauer J, Kellner K, Sack U, Stiehl P, Winkler J. Lung; 2001 Apr; 179(3):163-74. PubMed ID: 11891606 [Abstract] [Full Text] [Related]
4. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results? Schildge J, Nagel C, Grun C. Respiration; 2007 Apr; 74(5):553-7. PubMed ID: 17496412 [Abstract] [Full Text] [Related]
5. Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders. Capelli A, Lusuardi M, Cerutti CG, Donner CF. Am J Respir Crit Care Med; 1997 Jan; 155(1):249-53. PubMed ID: 9001320 [Abstract] [Full Text] [Related]
6. [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases]. Kopiński P, Przybylski G, Jarzemska A, Sładek K, Soja J, Iwaniec T, Balicka-Slusarczyk B, Pinis G, Dyczek A, Szabłowska K, Golińska J, Jankowski M, Szczeklik J. Pol Merkur Lekarski; 2007 Jul; 23(133):15-21. PubMed ID: 18051824 [Abstract] [Full Text] [Related]
7. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio]. Zielonka TM, Wałajtys-Rode E, Jasińska R, Chazan R, Droszcz W. Przegl Lek; 1999 Jul; 56(2):144-7. PubMed ID: 10375948 [Abstract] [Full Text] [Related]
8. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases. Petkova D, Xaubet A, Picado C, Filella X, Agusti C, Luburich P, Rodriguez-Roisin R. Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432 [Abstract] [Full Text] [Related]
14. Chitotriosidase activity in patients with interstitial lung diseases. Bargagli E, Margollicci M, Luddi A, Nikiforakis N, Perari MG, Grosso S, Perrone A, Rottoli P. Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992 [Abstract] [Full Text] [Related]
15. [Measurement of total glutathione concentration in bronchoalveolar lavage recovered from the patients with diffuse interstitial lung disease]. He QY, Ishii Y, Kitamura S. Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):24-6, 61. PubMed ID: 8082213 [Abstract] [Full Text] [Related]